Ondine Biomedical Inc (OBI) NPV

- Add to watchlist
- Create an alert
- This stock can be held in a




Share news, reports & tips
-
Ondine Biomedical upbeat on new Steriwave test data
9 June 2025 15:59
(Sharecast News) - Ondine Biomedical announced new data from University College London on Monday, showing that its Steriwave photodisinfection technology is effective against Mucor, a highly lethal fungal...
-
Ondine's Steriwave adopted by Ottawa Heart Institute
5 June 2025 12:28
(Sharecast News) - Ondine Biomedical announced on Thursday that the University of Ottawa Heart Institute (OHI) had adopted its Steriwave nasal photodisinfection therapy as a standard of care for all cardiac...
-
Ondine appoints Alan Thomas as interim finance chief
9 May 2025 12:50
(Sharecast News) - Ondine Biomedical announced the appointment of Alan Thomas as its interim chief financial officer on Friday, with immediate effect, following the departure of Michael Behlke, who was...
-
Ondine Biomedical upbeat on cost-saving potential of Steriwave product
9 April 2025 13:28
(Sharecast News) - Ondine Biomedical said in an update on Wednesday that a new health economic analysis by the York Health Economics Consortium (YHEC) supported significant cost-saving potential from its...
-
Ondine appoints new finance, operations chief
26 February 2025 12:39
(Sharecast News) - Ondine Biomedical announced the appointment of Michael Behlke as its chief financial and chief operating officer on Wednesday, strengthening its leadership team as the company advanced its...
-
Ondine Biomedical gets $4m investment from HCA Healthcare subsidiary
27 January 2025 15:44
(Sharecast News) - Ondine Biomedical announced a $4m equity investment from hInsight-NX, a subsidiary of US medical facilities giant HCA Healthcare, on Monday, extending its cash runway through to the fourth...
-
Ondine enrols first patient in phase three clinical trial
30 December 2024 10:02
(Sharecast News) - Ondine Biomedical announced the launch of its phase three clinical trial for 'light-activated antimicrobial therapy to prevent surgical site infections' (LANTERN) on Monday,...
-
Ondine enrols first patient in phase three clinical trial
30 December 2024 10:02
(Sharecast News) - Ondine Biomedical announced the launch of its phase three clinical trial for 'light-activated antimicrobial therapy to prevent surgical site infections' (LANTERN) on Monday,...
-
Ondine Biomedical to start phase three Steriwave clinical trial
17 December 2024 12:32
(Sharecast News) - Ondine Biomedical announced on Tuesday that it would begin its phase three 'LANTERN' clinical trial for its novel nasal photodisinfection technology, branded as Steriwave outside...
-
Ondine raising £8.5m to fund US clinical trial
1 November 2024 10:47
(Sharecast News) - Ondine Biomedical announced a proposed minimum £8.5m fundraising through a placing and subscription of new shares on Friday, priced at 8.5p each, to support the US phase three clinical...
-
Ondine Biomedical gets UAE approval for Steriwave
18 October 2024 12:04
(Sharecast News) - Ondine Biomedical announced on Friday that it has received regulatory approval to market its 'Steriwave' nasal decolonisation technology in the United Arab Emirates.
-
Ondine Biomedical's Steriwave added to NHS Supply Chain
21 June 2024 13:14
(Sharecast News) - Life science company Ondine Biomedical announced on Friday that its 'Steriwave' nasal photodisinfection treatment was now available through the NHS Supply Chain.
Company announcements Announcements
-
Ondine Appoints Peel Hunt as Broker
1 July 2025 07:00
Ondine Biomedical Inc. NPV (CDI)
-
Leading Canadian Surgery Centre Adopts Steriwave
30 June 2025 07:00
Ondine Biomedical Inc. NPV (CDI)
-
Result of AGM and voting results
26 June 2025 18:02
Ondine Biomedical Inc. NPV (CDI)
-
Steriwave Standard of Care in 2nd Health Authority
25 June 2025 07:00
Ondine Biomedical Inc. NPV (CDI)
-
Second Quebec Hospital Adopts Steriwave
19 June 2025 07:00
Ondine Biomedical Inc. NPV (CDI)
-
UK Doctor Wins Award for NHS Steriwave Innovation
16 June 2025 07:00
Ondine Biomedical Inc. NPV (CDI)
-
NHS Trust up for HSJ Award for Steriwave Use
12 June 2025 07:00
Ondine Biomedical Inc. NPV (CDI)
-
Ondine Presents Groundbreaking Findings
10 June 2025 07:29
Ondine Biomedical Inc. NPV (CDI)
-
Exercise of Options
10 June 2025 07:00
Ondine Biomedical Inc. NPV (CDI)
-
UCL Shows Steriwave Effective Against Mucor Fungus
9 June 2025 07:00
Ondine Biomedical Inc. NPV (CDI)
-
Canada's Largest Cardiac Centre Adopts Steriwave
5 June 2025 07:00
Ondine Biomedical Inc. NPV (CDI)
-
Notice of AGM
4 June 2025 07:00
Ondine Biomedical Inc. NPV (CDI)
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2025. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.